Luigi Chieco-Bianchi

Luigi Chieco-Bianchi

Auto-generated profile, based on publicly available information

Luigi Chieco-Bianchi

Affiliations of authors: A. M. Cattelan, F. Meneghetti (Department of Infectious Diseases), S. M. L. Aversa (Department of Medical Oncology), General Hospital of Padova, Italy; M. L. Calabrò, P. Gasperini, M. Zanchetta, A. De Rossi, L. Chieco-Bianchi, Department of Oncology and Surgical Sciences, Oncology Section, AIDS Reference Centre, University of Padova, Italy

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2000 in JNCI Monographs
Verified
Journal Article
Open access
PDF file
ACAnna Maria Cattelan
Anna Maria Cattelan
Maria Luisa Calabro'Maria Luisa Calabro'
Maria Luisa Calabro'
PGPaola Gasperini
Paola Gasperini
SASavina M. L. Aversa
Savina M. L. Aversa
MZMarisa Zanchetta
Marisa Zanchetta
LCLuigi Chieco-Bianchi
Luigi Chieco-Bianchi
Background: Kaposi's sarcoma (KS) is the most common cancer seen in subjects with acquired immunodeficiency syndrome (AIDS). KS etiology and pathogenesis are still ill defined, and no definite improvement in survival has been obtained with current chemotherapeutic regimens. This open prospective study was aimed at evaluating the clinical response of AIDS-related KS to highly active antiretroviral therapy (HAART), a combination of protease and reverse transcriptase inhibitors, as well as the relationship between clinical response, human immunodeficiency virus type 1 (HIV-1) burden, and antibody titer against human herpesvirus 8 (HHV8) proteins. Patients and Methods: Fourteen KS patients were studied; 12 were in the poor-risk group. At given intervals, the patients underwent clinical examination, and their CD4+ cell counts, plasma HIV-1 RNA levels, and antibody titers to lytic-phase ORF65 and latent-phase HHV8 proteins were determined. Results: When last seen, the overall clinical response rate was 86% (median follow-up, 22 months); 10 complete and two partial responses were achieved, and two patients showed disease progression. All patients with complete or partial response showed a consistent decrease in HIV-1 RNA levels, with a corresponding increase in CD4+ cell counts; HIV-1 RNA levels in the two progressors remained persistently high, despite a change in HAART. HHV8 ORF65 antibody titers were generally higher in patients with extensive skin or mucosal/visceral involvement versus patients with limited disease; no differences in latent-phase HHV8 antibody titers were observed in relation to tumor burden. Conclusion: The findings indicate that antiretroviral therapy with protease inhibitors is effective for AIDS-related KS; the clinical response was correlated with a decrease in plasma HIV-1 RNA levels and an increase in CD4+ lymphocytes, whereas antibody levels to the lytic-phase HHV8 protein were influenced by the extent of tumor involvement.

1 June 1999 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
Maria Luisa Calabro'Maria Luisa Calabro'
Maria Luisa Calabro'
JFJose' Ramon Fiore
Jose' Ramon Fiore
AFAnna Favero
Anna Favero
ALAchiropita Lepera
Achiropita Lepera
ASAnnalisa Saracino
Annalisa Saracino
LCLuigi Chieco‐Bianchi
Luigi Chieco‐Bianchi
Epidemiologic studies suggest that human herpesvirus 8 (HHV-8) may be sexually transmitted. To study the potential for HHV-8 transmission through cervicovaginal (CV) secretions, the presence of HHV-8 DNA was investigated by nested polymerase chain reaction in the cellular fraction of CV secretions from 36 human immunodeficiency virus type 1 (HIV-1)-seropositive and 29 HIV-1—seronegative women. The same patients were tested for antibodies to two defined HHV-8 antigens (latency-associated nuclear antigen and open-reading frame 65-encoded structural protein) and for HHV-8 DNA in their peripheral blood mononuclear cells (PBMC). The findings were compared with the rate of HHV-8 detection in semen samples of 20 HIV-1—infected men. HHV-8 DNA was detected in the CV samples from only 1 HHV-8-seropositive AIDS patient, in 3 PBMC samples (1/29 HIV-1—seronegative patients, 1/3 AIDS patients with Kaposi's sarcoma, and 1/19 AIDS patients), and in 1 of 20 semen samples. HHV-8 infection was more common in HIV-1—infected than uninfected women. Thus HHV-8 DNA is only rarely detectable in CV secretions and semen of HHV-8—infected individuals.

1 December 1990 in American Journal of Clinical Pathology
Verified
Journal Article
Open access
PDF file
AMAnnarosa Del Mistro
Annarosa Del Mistro
ALAnnamaria Laverda
Annamaria Laverda
FCFiorella Calabrese
Fiorella Calabrese
MMMaurizio De Martino
Maurizio De Martino
PKPamela G. Kidd
Pamela G. Kidd
LCLuigi Chieco-Bianchi
Luigi Chieco-Bianchi
Postmortem examination disclosed central nervous system non-Hodgkin's lymphoma in two children who died of acquired immune deficiency syndrome (AIDS) at 6 and 14 months of age, respectively. Systemic signs of lymphoma were not present. The B-cell origin and clonality of the neoplastic cells were established by immunohistochemistry in one case and by molecular analysis of immunoglobulin gene rearrangement in the other. Moreover, in the latter case the neoplastic cells were characterized by the presence of a single episomal EBV genome. According to these data, the monoclonal B-cell proliferation occurred after EBV infection, thus suggesting a possible pathogenetic role of EBV in the early stages of lymphomagenesis.

1 July 2003
Verified
Journal Article
Closed access
CMChiara Menin
Chiara Menin
Pier Paolo PiccalugaPier Paolo Piccaluga
Pier Paolo Piccaluga
FFFausto Filippi
Fausto Filippi
MBMauro Buttarello
Mauro Buttarello
CCConcepcion Casado
Concepcion Casado
AMAnnarosa Del Mistro
Annarosa Del Mistro